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204  |  Over-the-counter (OTC) Non-Steroidal 
Anti-inflammatory Drugs (NSAIDs): How much do 
consumers really know?
Mullan J 1, Weston K 1, Bonney A 1, Magee C 1, Mullan J 2
1 Graduate School of Medicine, University of Wollongong, 2 Dapto Centretown Pharmacy
Background: Many Australians purchase over-the-counter (OTC) Non-Steroidal Anti-
inflammatory Drugs (NSAIDs). If not taken appropriately, these medications can cause 
severe adverse events. This study aimed to investigate consumers knowledge of these 
preparations and their potential side effects. 
Methods: Customers aged over 18 years purchasing OTC Nurofen and/or Nurofen Plus 
from seven NSW community pharmacies, located in different socio-economic areas, were 
asked to complete an anonymous survey between January - August 2013. The survey 
questionnaire assessed the customers health literacy skills along with demographic data, 
as well as their knowledge about active ingredients, the maximum recommended daily 
dosage and common side effects associated with taking these products.  
Results: In total, 263 consumers completed the surveys (180 females). The majority (71%, 
n=187) had attended school to Year 11 or higher and had high health literacy skills. One 
third (32%;n=84) did not know the maximum recommended daily dose; 17% (n=45) did 
not know that ibuprofen was the active ingredient and 40% (n=105) thought that aspirin 
was an active ingredient in these products. Moreover, 42% (n=110) and 48% (n=126) did not 
know that taking these products could cause gastrointestinal disturbance and/or bleeding, 
respectively.  
Discussion: The findings of this study highlight that pharmacists need to play more of 
an active role in educating all consumers about the potential for NSAID-related adverse 
effects. Despite high health literacy, a significant number of consumers could not identify 
the active ingredient and the recommended maximum daily dose, increasing the risk of 
unintentional NSAID-related harm from these products. The results also suggest that the 
scheduling for NSAIDs needs to be reviewed to ensure consumers can be provided with 
the necessary education and information about these products at the point of purchase. 
